Mutations in immunoglobulin-producing moose myeloma cells

Reuben Baumal, Barbara K. Birshtein, Philip Coffino, Matthew D. Scharff

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Three mouse myeloma cell lines were cloned in soft agar and screened by an antiserum overlay method for variants defective in secretion of the myeloma protein. Variants that had lost the capacity to synthesize heavy chains arose spontaneously at a high rate of about 10-3 per cell per generation. Such variants lost the capacity to produce light chains at a similarly high rate. After cells were treated with the acridine half mustard ICR-191, variants occurred with an even higher incidence, and some of these synthesized heavy chains differing from that of the parent.

Original languageEnglish (US)
Pages (from-to)164-166
Number of pages3
JournalScience
Volume182
Issue number4108
StatePublished - 1973

Fingerprint

Immunoglobulins
Myeloma Proteins
Mutation
Agar
Immune Sera
Light
Cell Line
Incidence
acridine half-mustard

ASJC Scopus subject areas

  • General

Cite this

Baumal, R., Birshtein, B. K., Coffino, P., & Scharff, M. D. (1973). Mutations in immunoglobulin-producing moose myeloma cells. Science, 182(4108), 164-166.

Mutations in immunoglobulin-producing moose myeloma cells. / Baumal, Reuben; Birshtein, Barbara K.; Coffino, Philip; Scharff, Matthew D.

In: Science, Vol. 182, No. 4108, 1973, p. 164-166.

Research output: Contribution to journalArticle

Baumal, R, Birshtein, BK, Coffino, P & Scharff, MD 1973, 'Mutations in immunoglobulin-producing moose myeloma cells', Science, vol. 182, no. 4108, pp. 164-166.
Baumal R, Birshtein BK, Coffino P, Scharff MD. Mutations in immunoglobulin-producing moose myeloma cells. Science. 1973;182(4108):164-166.
Baumal, Reuben ; Birshtein, Barbara K. ; Coffino, Philip ; Scharff, Matthew D. / Mutations in immunoglobulin-producing moose myeloma cells. In: Science. 1973 ; Vol. 182, No. 4108. pp. 164-166.
@article{f56167a5586a4c85b4d06add4ec48010,
title = "Mutations in immunoglobulin-producing moose myeloma cells",
abstract = "Three mouse myeloma cell lines were cloned in soft agar and screened by an antiserum overlay method for variants defective in secretion of the myeloma protein. Variants that had lost the capacity to synthesize heavy chains arose spontaneously at a high rate of about 10-3 per cell per generation. Such variants lost the capacity to produce light chains at a similarly high rate. After cells were treated with the acridine half mustard ICR-191, variants occurred with an even higher incidence, and some of these synthesized heavy chains differing from that of the parent.",
author = "Reuben Baumal and Birshtein, {Barbara K.} and Philip Coffino and Scharff, {Matthew D.}",
year = "1973",
language = "English (US)",
volume = "182",
pages = "164--166",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "4108",

}

TY - JOUR

T1 - Mutations in immunoglobulin-producing moose myeloma cells

AU - Baumal, Reuben

AU - Birshtein, Barbara K.

AU - Coffino, Philip

AU - Scharff, Matthew D.

PY - 1973

Y1 - 1973

N2 - Three mouse myeloma cell lines were cloned in soft agar and screened by an antiserum overlay method for variants defective in secretion of the myeloma protein. Variants that had lost the capacity to synthesize heavy chains arose spontaneously at a high rate of about 10-3 per cell per generation. Such variants lost the capacity to produce light chains at a similarly high rate. After cells were treated with the acridine half mustard ICR-191, variants occurred with an even higher incidence, and some of these synthesized heavy chains differing from that of the parent.

AB - Three mouse myeloma cell lines were cloned in soft agar and screened by an antiserum overlay method for variants defective in secretion of the myeloma protein. Variants that had lost the capacity to synthesize heavy chains arose spontaneously at a high rate of about 10-3 per cell per generation. Such variants lost the capacity to produce light chains at a similarly high rate. After cells were treated with the acridine half mustard ICR-191, variants occurred with an even higher incidence, and some of these synthesized heavy chains differing from that of the parent.

UR - http://www.scopus.com/inward/record.url?scp=0015814177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015814177&partnerID=8YFLogxK

M3 - Article

VL - 182

SP - 164

EP - 166

JO - Science

JF - Science

SN - 0036-8075

IS - 4108

ER -